We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Glaxo Agrees To $65M Settlement In Antitrust Suit Over Paxil Patent Gaming: Report

Law360 (February 3, 2005, 12:00 AM EST) -- In a deal that closely resembles similar settlements for arthritis drug Relafen and prescription antibiotic Augmentin, GlaxoSmithKline has reportedly agreed to pay $65 million to settle a class action antitrust suit...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.